Chloroquine Phosphate/Proguanil Hydrochloride

Product Name :
Chloroquine Phosphate/Proguanil Hydrochloride

Search keywords :
DHFR

drugId :
null

Target Vo:
Dihydrofolate reductase

Target Vo Short Name :
DHFR

Moa_Name:
Dihydrofolate reductase inhibitors

First Approval Country :
France

First Approval Date Filter:
1999

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :
Astrazeneca Pharmaceutical Co Ltd

Active Indication_Name:
Malaria

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AIF Antibody (YA835)
CD79a Antibody
ENO1 Antibody (YA773): ENO1 Antibody (YA773) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to ENO1 (3F7). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts